Commercialization

>

Latest News

PharmaCord, Mercalis Merge in an Effort to Support the Patient Journey
PharmaCord, Mercalis Merge in an Effort to Support the Patient Journey

March 12th 2025

The partnership focuses on enhancing the patient experience by providing greater affordability and access to specialty meds.

Selardsi Launches in the US Market
Selardsi Launches in the US Market

February 24th 2025

Popping the Gross-to-Net Bubble, Part II: What Manufacturers Can Do About It
Popping the Gross-to-Net Bubble, Part II: What Manufacturers Can Do About It

February 6th 2025

FDA Accepts Review of Golimumab Biosimilar
FDA Accepts Review of Golimumab Biosimilar

January 27th 2025

Newron, Myung In Pharm Form Partnership Centered Around Treating Schizophrenia in South Korea
Newron, Myung In Pharm Form Partnership Centered Around Treating Schizophrenia in South Korea

January 14th 2025

More News

J&J Inks $14.6 Billion Intra-Cellular Therapies Deal

J&J Inks $14.6 Billion Intra-Cellular Therapies Deal

Nicholas Saraceno, Editor
January 13th 2025

The acquisition features Caplyta as part of its neuroscience portfolio, which is considered the only FDA-approved treatment for bipolar I and II depression as a monotherapy and adjunctive treatment.

© 2025 MJH Life Sciences

All rights reserved.